Literature DB >> 31720928

A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.

Davide Ferrari1,2, Valentina Garrapa3, Massimo Locatelli4, Angelo Bolchi3,5.   

Abstract

Single-domain antigen-binding fragments of camelid antibodies, known as VHHs or nanobodies, are widely used affinity reagents. However, their production involving animal immunization is time- and resource-intensive. Starting from a sequence dataset of llama VHHs, we designed a novel scaffold, based on conserved framework sequences, suitable for bacterial nanobody expression and synthetic library construction. The consensus scaffold was validated by grafting the CDRs from two known nanobodies. While maintaining their binding properties, the two chimeric nanobodies showed higher levels of expression and solubility in E. coli when compared to the corresponding wild types. A proof-of-concept synthetic combinatorial library, suitable for ribosome display (RD) selection, was obtained by encoding three randomized complementarity determining regions within the consensus framework. The library, made of linear DNA fragments, has an estimated complexity of > 1012 that is three orders of magnitude higher than common phage display libraries. The bacterial expression of several library clones showed a high production of soluble recombinant proteins. The high complexity of the library, confirmed by sequencing of a subset of clones, as well as a preliminary RD selection of a maltose binding protein binder, indicated this approach as a starting point in the construction of synthetic combinatorial libraries to be used as animal-free tools for the low-cost selection of target-specific nanobodies.

Entities:  

Keywords:  Library; Nanobody; Ribosome display; Scaffold; VHH

Mesh:

Substances:

Year:  2020        PMID: 31720928     DOI: 10.1007/s12033-019-00224-z

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  41 in total

1.  Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.

Authors:  M M Harmsen; R C Ruuls; I J Nijman; T A Niewold; L G Frenken; B de Geus
Journal:  Mol Immunol       Date:  2000-08       Impact factor: 4.407

2.  Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library.

Authors:  Kerrm Y F Yau; Maria A T Groves; Shenghua Li; Claudia Sheedy; Hung Lee; Jamshid Tanha; C Roger MacKenzie; Lutz Jermutus; J Christopher Hall
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

3.  In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na(+)-citrate symporter CitS as an example.

Authors:  Thomas Huber; Daniel Steiner; Daniela Röthlisberger; Andreas Plückthun
Journal:  J Struct Biol       Date:  2007-02-03       Impact factor: 2.867

4.  Nanobodies and their potential applications.

Authors:  Gholamreza Hassanzadeh-Ghassabeh; Nick Devoogdt; Pieter De Pauw; Cécile Vincke; Serge Muyldermans
Journal:  Nanomedicine (Lond)       Date:  2013-06       Impact factor: 5.307

5.  Modulation of protein properties in living cells using nanobodies.

Authors:  Axel Kirchhofer; Jonas Helma; Katrin Schmidthals; Carina Frauer; Sheng Cui; Annette Karcher; Mireille Pellis; Serge Muyldermans; Corella S Casas-Delucchi; M Cristina Cardoso; Heinrich Leonhardt; Karl-Peter Hopfner; Ulrich Rothbauer
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

6.  Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.

Authors:  M Lauwereys; M Arbabi Ghahroudi; A Desmyter; J Kinne; W Hölzer; E De Genst; L Wyns; S Muyldermans
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

7.  A general protocol for the generation of Nanobodies for structural biology.

Authors:  Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

Review 8.  Targeting tumors with nanobodies for cancer imaging and therapy.

Authors:  Sabrina Oliveira; Raimond Heukers; Jirawas Sornkom; Robbert J Kok; Paul M P van Bergen En Henegouwen
Journal:  J Control Release       Date:  2013-09-11       Impact factor: 9.776

9.  Naturally occurring antibodies devoid of light chains.

Authors:  C Hamers-Casterman; T Atarhouch; S Muyldermans; G Robinson; C Hamers; E B Songa; N Bendahman; R Hamers
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

Review 10.  Nanobody: the "magic bullet" for molecular imaging?

Authors:  Rubel Chakravarty; Shreya Goel; Weibo Cai
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

View more
  5 in total

Review 1.  Exploring cellular biochemistry with nanobodies.

Authors:  Ross W Cheloha; Thibault J Harmand; Charlotte Wijne; Thomas U Schwartz; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2020-08-31       Impact factor: 5.157

Review 2.  Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).

Authors:  Sheng Yu; Gui Xiong; Shimei Zhao; Yanbo Tang; Hua Tang; Kaili Wang; Hongjing Liu; Ke Lan; Xiongjie Bi; Siliang Duan
Journal:  Int J Mol Med       Date:  2020-12-14       Impact factor: 4.101

Review 3.  Current and future advances in fluorescence-based visualization of plant cell wall components and cell wall biosynthetic machineries.

Authors:  Brian T DeVree; Lisa M Steiner; Sylwia Głazowska; Felix Ruhnow; Klaus Herburger; Staffan Persson; Jozef Mravec
Journal:  Biotechnol Biofuels       Date:  2021-03-29       Impact factor: 6.040

Review 4.  Structural Insights into the Design of Synthetic Nanobody Libraries.

Authors:  Mario S Valdés-Tresanco; Andrea Molina-Zapata; Alaín González Pose; Ernesto Moreno
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

Review 5.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.